Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Liabilities and Shareholders Equity (2016 - 2025)

Avricore Health has reported Liabilities and Shareholders Equity over the past 12 years, most recently at $403809.2 for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 75.46% to $403809.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 48.25% year-over-year, with the annual reading at $403040.6 for FY2025, 75.99% down from the prior year.
  • Liabilities and Shareholders Equity was $403809.2 for Q4 2025 at Avricore Health, down from $965908.6 in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.2 million in Q3 2024 and troughed at $403809.2 in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $1.8 million (2021), against an average of $1.7 million.
  • Year-over-year, Liabilities and Shareholders Equity surged 649.04% in 2021 and then crashed 75.46% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.8 million in 2021, then increased by 4.57% to $1.9 million in 2022, then fell by 1.49% to $1.9 million in 2023, then decreased by 11.75% to $1.6 million in 2024, then crashed by 75.46% to $403809.2 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Liabilities and Shareholders Equity are $403809.2 (Q4 2025), $965908.6 (Q3 2025), and $1.2 million (Q2 2025).